HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,464,000 | +614.1% | 750,000 | +328.6% | 0.00% | – |
| Q3 2019 | $205,000 | -63.1% | 175,000 | -65.0% | 0.00% | -100.0% |
| Q2 2019 | $555,000 | -1.6% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $564,000 | +13.5% | 500,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $497,000 | +158.9% | 500,000 | +150.0% | 0.00% | – |
| Q2 2018 | $192,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 99,100,000 | $94,914,000 | 3.33% |
| Lion Point Capital, LP | 16,000,000 | $15,312,000 | 1.38% |
| SYMPHONY ASSET MANAGEMENT LLC | 5,000,000 | $4,804,000 | 0.96% |
| LINDEN ADVISORS LP | 32,106,000 | $30,888,000 | 0.95% |
| OAKTREE CAPITAL MANAGEMENT LP | 46,262,000 | $44,449,000 | 0.62% |
| Nicholas Investment Partners, LP | 8,635,000 | $8,264,000 | 0.58% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 16,785,000 | $16,100,000 | 0.34% |
| CANYON CAPITAL ADVISORS LLC | 30,000,000 | $28,712,000 | 0.32% |
| SSI INVESTMENT MANAGEMENT LLC | 3,250,000 | $3,110,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,278,000 | $6,031,000 | 0.17% |